← All organizations

Pharmacia

For profitContributed to NME

Also known as: PHARMACIA | Pharmacia Corporation | Pharmacia GmbH, Erlangen, Germany | Pharmacia Pharmaceutical Company | PHARMACIA SAS | Pharmacia (v1) | Pharmacia (v2)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

First NDA

Last known activity

Jan 1, 2005

Acquired by Pfizer on Apr 16, 2003

Timeline

1910s

Jun 1, 1911
Pharmacia— Founded

1970s

Feb 26, 1979
phenytoin— Marketing Organization

1980s

Jan 1, 1980
Adria Laboratories— Acquired

1990s

Feb 21, 1992
lomefloxacin— NDA Organization
Dec 1, 1999
Monsanto— Acquired

2000s

Jan 1, 2000
Pharmacia & Upjohn— Acquired
Aug 18, 2000
sulfasalazine— NDA Secondary Org
Mar 7, 2001
Sensus— Acquired
Apr 16, 2003
Pfizer— Acquired By

Drugs by trial phase (70 distinct, 76 trials)

Phase 4 (4 own, 2 via acquisition)

Phase 3 (5 own, 24 via acquisition)

Phase 2 (3 own, 13 via acquisition)

Phase 1 (2 own, 3 via acquisition)

Other trials (4 own, 10 via acquisition)

Subsidiaries (4 direct, 13 total across the full acquisition tree)

Recent trials (26)

NCT00612638CollaboratorPhase 1Jan 1, 2005
NCT00470002CollaboratorPhase 1May 1, 2004
NCT00211952CollaboratorPhase 3Mar 1, 2004
NCT00072319CollaboratorPhase 2Aug 1, 2003
NCT00777075CollaboratorPhase 4Jul 1, 2003
NCT00231829CollaboratorPhase 2Apr 1, 2003
NCT00062179CollaboratorPhase 2Mar 1, 2003
NCT00353015CollaboratorPhase 2Mar 1, 2003
NCT00581971CollaboratorPhase 1/Phase 2Sep 1, 2002
NCT00544232CollaboratorPhase 3Aug 1, 2002
NCT00146588CollaboratorN/AApr 1, 2002
NCT01031992CollaboratorPhase 3Mar 1, 2002
NCT00137852CollaboratorPhase 2Jan 1, 2002
NCT00919399CollaboratorPhase 2Jan 1, 2002
NCT00582660CollaboratorPhase 2Dec 1, 2001

Details

Founded: Stockholm, SE Jun 1, 1911
First NDA: Feb 21, 1992
Last known activity: Jan 1, 2005

Designations held

Orphan drug
Priority review
Accelerated approval